For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .
As a an internal medicine physician, I am often faced with patients who have conditions that result from immune system dysfunctions. These inflammatory or autoimmune diseases are often rare diseases whose causes and symptoms are misunderstood: lupus, myositis autoimmune diseases, immune deficiencies in adults, systemic fibrosis, etc.
Like Marseille Immunopole, our discipline is positioned at the interface of different medical specialties, but also of fundamental and translational research. For many years our service at the Timone Hospital has collaborated with researchers including the ” Natural Killer Cells and Innate Immunity” team of Eric VIVIER at CIML. Together, we have developed a laboratory at the Conception Hospital specializing in the functional exploration of these lymphocytes and rare lymphocyte populations. We are conducting studies to better understand their involvement in diseases such as Systemic Lupus Erythematosus, Immune Thrombocytopenia Purpura (ITP) or IgG4-related diseases. The laboratory has also developed a routine battery of tests to quantify and qualify the activity of NK cells, T helper cells (Th) and Innate Lymphoid Cells (ILCs), particularly in clinical trials.#clinique
MI-mAbs allows researchers to validate the therapeutic potential of their discovery and permits industrials to focus their efforts on the most promising drug candidate
The thrust of MI is the ability of Marseille researchers, clinicians and industrials to play as a team.
Diagnostic in immuno-oncology is an innovative field combining the latest discoveries in immunology and new imaging technologies, such as digital pathology.
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.